Shashank Joshi: The Emerging Role of Inflammatory Biomarkers in Acute CVS Thrombosis
Shashank Joshi, Senior Consultant at Joshi Clinic and President of Indian Academy of Diabetes, shared post on LinkedIn about a recent article by Leonardo Cruz-Criollo et al, published in Stroke, adding:
“Serum inflammatory biomarkers may aid early risk stratification in patients with acute cerebral venous sinus thrombosis.”
Title: Early Inflammatory Biomarkers Associated With Functional Outcomes in Acute Cerebral Venous Thrombosis: CLOT-VENUS Substudy
Authors: Leonardo Cruz-Criollo, Milagros Galecio-Castillo, Aaron Rodriguez-Calienes, Piyush Kalakoti, Vanessa Cano-Nigenda, Anderson Brito, Miguel Barboza, Jason Gao, Andres Mercado, Adrian Pereda, Jason Lefkowitz, Jorge Cespedes, Nashwa Abdelhakim, Binbin Zheng-Lin, Amir Shaban, Brian J. Smith, Nicholas M. Mohr, Antonio Arauz, Santiago Ortega-Gutierrez
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 30, 2026, 05:30John Bramble: Ensuring Safe AI Integration in Medicine
-
Apr 30, 2026, 04:55Danielle Stull: Raising Awareness of CVS Thrombosis in Young Women
-
Apr 29, 2026, 17:25Robert Brodsky: Ravulizumab Appears To Be Safe And Effective In Pregnancy
-
Apr 29, 2026, 16:53Chokri Ben Lamine: IV Iron Showdown – FCM vs Ferric Derisomaltose vs Iron Dextran
-
Apr 29, 2026, 16:46Deep Vein Thrombosis Risk in Jobs with Prolonged Sitting – NBCA
-
Apr 29, 2026, 16:41Vikramaditya Gangakar: Essential Pharmacy Facts You Should Know About Aspirin
-
Apr 29, 2026, 16:17W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
-
Apr 29, 2026, 16:12Mavis Agnes Kisakye: Concluding a Successful Entrepreneurs Training for Empowering Ptients’ Mothers
-
Apr 29, 2026, 15:48Kriti Batni: Happy to Share Current Use and Future Directions of Monoclonal Antibodies in Medicine Update 2026